Takeda Pharmaceutical Co. (TAK)
(Delayed Data from NYSE)
$13.35 USD
+0.32 (2.46%)
Updated May 31, 2024 03:59 PM ET
After-Market: $13.36 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/25/24 |
---|---|
Current Quarter | 0.42 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | NA |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.47 |
Next Year | 1.63 |
EPS (TTM) | 1.56 |
P/E (F1) | 9.06 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 27.52B |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 27.81B |
Low Estimate | NA | NA | NA | 27.22B |
Year ago Sales | 7.71B | 6.94B | 27.57B | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.42 | NA | 1.47 | 1.63 |
# of Estimates | 1 | NA | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.42 | NA | 1.56 | 1.84 |
Low Estimate | 0.42 | NA | 1.41 | 1.40 |
Year ago EPS | 0.55 | 0.50 | 1.67 | 1.47 |
Year over Year Growth Est. | -23.64% | NA | -11.98% | 10.88% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 1 | 0 |
Down Last 60 Days | 0 | NA | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 0.42 | NA | 1.47 | 1.63 |
7 Days Ago | 0.42 | NA | 1.47 | 1.63 |
30 Days Ago | NA | NA | 1.55 | 1.62 |
60 Days Ago | NA | NA | 1.55 | 1.62 |
90 Days Ago | NA | NA | 1.16 | 1.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.42 | NA | 1.41 | 1.66 |
Zacks Consensus Estimate | 0.42 | NA | 1.47 | 1.63 |
Earnings ESP | 0.00% | NA | -4.30% | 1.64% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | 0.51 | 0.50 | 0.55 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more